Drug intelligence / Profile preview

rictor siRNA

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral
01

Overview

Rictor siRNA is a small interfering RNA (siRNA) designed to silence the expression of the Rictor (Rapamycin-insensitive companion of mTOR) gene. Rictor is an essential subunit of the mechanistic target of rapamycin complex 2 (mTORC2), which regulates cell survival, metabolism, and cytoskeleton organization. By knocking down Rictor, this siRNA inhibits the assembly and activity of mTORC2, leading to reduced phosphorylation of downstream targets such as Akt (at Ser473) and protein kinase C (PKC). In research settings, Rictor siRNA is used to investigate the role of the mTORC2 pathway in various conditions, including triple-negative breast cancer, glioblastoma, gastric cancer, and diabetic nephropathy. It has demonstrated the ability to suppress tumor cell proliferation, migration, and invasion, and to sensitize cells to apoptosis. Delivery systems such as graphene oxide nanoparticles have been explored to enhance its uptake and efficacy in tumor models.

Other names
RICTOR siRNAsiRICTORRictor small interfering RNA
02

Targets

RICTOR

Beyond the preview

Go deeper on rictor siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rictor siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call